EFNS guidelines on the molecular diagnosis of mitochondrial disorders
- PMID: 19950421
- DOI: 10.1111/j.1468-1331.2009.02811.x
EFNS guidelines on the molecular diagnosis of mitochondrial disorders
Abstract
Objectives: These European Federation of Neurological Sciences (EFNS) guidelines are designed to provide practical help for the general neurologist to make appropriate use of molecular genetics for diagnosing mitochondrial disorders (MIDs), which gain increasing attention and are more frequently diagnosed due to improved diagnostic tools.
Background: Since the publication of the first EFNS guidelines on the molecular diagnosis of inherited neurological diseases in 2001, rapid progress has been made in this field, necessitating the creation of an updated version.
Search strategy: To collect data about the molecular diagnosis of MIDs search for literature in various electronic databases, such as Cochrane library, MEDLINE, OMIM, GENETEST or Embase, were carried out and original papers, meta-analyses, review papers, and guideline recommendations were reviewed.
Results: The guidelines summarise the possibilities and limitations of molecular genetic diagnosis of MIDs and provide practical recommendations and diagnostic criteria in accordance with the EFNS Scientific Committee to guide the molecular diagnostic work-up of MIDs.
Recommendations: The proposed guidelines suggest an approach to the molecular diagnosis of MIDs in a manner accessible to general neurologists.
Similar articles
-
EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington's disease, Parkinson's disease and dystonias.Eur J Neurol. 2009 Jul;16(7):777-85. doi: 10.1111/j.1468-1331.2009.02646.x. Epub 2009 May 12. Eur J Neurol. 2009. PMID: 19469830
-
EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias.Eur J Neurol. 2010 May;17(5):641-8. doi: 10.1111/j.1468-1331.2010.02985.x. Epub 2010 Mar 9. Eur J Neurol. 2010. PMID: 20298421
-
EFNS guidelines for the molecular diagnosis of neurogenetic disorders: motoneuron, peripheral nerve and muscle disorders.Eur J Neurol. 2011 Feb;18(2):207-217. doi: 10.1111/j.1468-1331.2010.03069.x. Eur J Neurol. 2011. PMID: 20500522
-
Cardiac manifestations of primary mitochondrial disorders.Int J Cardiol. 2014 Dec 20;177(3):754-63. doi: 10.1016/j.ijcard.2014.11.014. Epub 2014 Nov 5. Int J Cardiol. 2014. PMID: 25465824 Review.
-
Inherited mitochondrial disorders.Adv Exp Med Biol. 2012;942:187-213. doi: 10.1007/978-94-007-2869-1_8. Adv Exp Med Biol. 2012. PMID: 22399423 Review.
Cited by
-
Review and evaluation of the methodological quality of the existing guidelines and recommendations for inherited neurometabolic disorders.Orphanet J Rare Dis. 2015 Dec 30;10:164. doi: 10.1186/s13023-015-0376-9. Orphanet J Rare Dis. 2015. PMID: 26714856 Free PMC article. Review.
-
FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study.Lancet Neurol. 2011 Sep;10(9):806-18. doi: 10.1016/S1474-4422(11)70155-7. Epub 2011 Aug 3. Lancet Neurol. 2011. PMID: 21820356 Free PMC article.
-
MSeqDR: A Centralized Knowledge Repository and Bioinformatics Web Resource to Facilitate Genomic Investigations in Mitochondrial Disease.Hum Mutat. 2016 Jun;37(6):540-548. doi: 10.1002/humu.22974. Epub 2016 Mar 21. Hum Mutat. 2016. PMID: 26919060 Free PMC article.
-
Neurogenetics in Argentina: diagnostic yield in a personalized research based clinic.Genet Res (Camb). 2015;97:e10. doi: 10.1017/s0016672315000087. Genet Res (Camb). 2015. PMID: 25989649 Free PMC article.
-
Growth Differentiation Factor 15 Is a Novel Diagnostic Biomarker of Mitochondrial Diseases.Mol Neurobiol. 2017 Dec;54(10):8110-8116. doi: 10.1007/s12035-016-0283-7. Epub 2016 Nov 26. Mol Neurobiol. 2017. PMID: 27889897
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical